Using genetic information to improve healthcare for diverse populations in Indiana.
Implementing genomic medicine through pragmatic trials in diverse and underserved populations across Indiana.
['FUNDING_U01'] · INDIANA UNIVERSITY INDIANAPOLIS · NIH-11073201
This study is looking at how genetic testing can help improve treatment for African Americans in Indiana who have high blood pressure and kidney issues, and it will see if getting test results right away or later makes a difference in their health.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | INDIANA UNIVERSITY INDIANAPOLIS (nih funded) |
| Locations | 1 site (INDIANAPOLIS, UNITED STATES) |
| Trial ID | NIH-11073201 on ClinicalTrials.gov |
What this research studies
This research focuses on integrating genomic medicine into clinical practice, particularly for underserved populations in Indiana. It involves pragmatic clinical trials that recruit participants, specifically targeting African Americans with hypertension and chronic kidney disease. The trials will assess the impact of genetic testing results on treatment decisions and health outcomes, including blood pressure management. Participants will be randomized to receive genetic testing results immediately or after a delay, allowing researchers to evaluate the effectiveness of this approach in real-world settings.
Who could benefit from this research
Good fit: Ideal candidates for participation include African American adults with hypertension, with or without chronic kidney disease.
Not a fit: Patients who do not identify as African American or do not have hypertension or chronic kidney disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatments for hypertension and chronic kidney disease in African American populations.
How similar studies have performed: Previous research has shown promise in using genomic information to guide treatment decisions, indicating that this approach could be effective.
Where this research is happening
INDIANAPOLIS, UNITED STATES
- INDIANA UNIVERSITY INDIANAPOLIS — INDIANAPOLIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SKAAR, TODD C. — INDIANA UNIVERSITY INDIANAPOLIS
- Study coordinator: SKAAR, TODD C.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.